DalsnaFinance › IPOs › Royalty Pharma › IPO
Royalty Pharma plc completed its initial public offering on NASDAQ on June 16, 2020, pricing at $28.00 a share.
| Ticker | RPRX |
|---|---|
| Exchange | NASDAQ |
| Status | Completed |
| Listing date | June 16, 2020 |
| Offering price | $28.00 |
| Shares offered | 77,681,670 |
| Total raised | $2,175M |
Royalty Pharma plc sold 77,681,670 shares at $28.00 each on NASDAQ. Multiplied out, that is $2.18 billion in gross proceeds, the figure before underwriting discounts and offering expenses, and it agrees with the $2.17 billion total recorded for the deal.
Royalty Pharma plc — quote, profile and latest news →
Source: SEC EDGAR filings for Royalty Pharma plc. This page is general information, not investment advice.